Santen Pharmaceutical Co., Ltd. (SNPHF) Financials

SNPHF Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2023 3.0 billion 920.7 million
Sept. 30, 2023 2.9 billion 806.9 million
June 30, 2023 2.9 billion 804.7 million
March 31, 2023 3.2 billion 962.8 million

SNPHF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 213.3 million ?
Sept. 30, 2023 153.5 million ?
June 30, 2023 -2.7 million ?
March 31, 2023 35.7 million ?

SNPHF Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2023 51.8 million
Sept. 30, 2023 59.3 million
June 30, 2023 72.0 million
March 31, 2023 8.3 million

SNPHF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 591.1 million - -
Sept. 30, 2023 444.2 million - -
June 30, 2023 325.8 million - -
March 31, 2023 441.8 million - -

SNPHF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 2.5 million
Sept. 30, 2023 2.4 million
June 30, 2023 2.6 million
March 31, 2023 2.8 million

SNPHF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 11.5 million 40.8 million 153.0 million -
Sept. 30, 2023 15.1 million 41.2 million 148.0 million -
June 30, 2023 20.3 million 43.6 million 145.7 million -
March 31, 2023 29.6 million 49.8 million 231.5 million -

SNPHF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 546.2 million 227.9 million
Sept. 30, 2023 491.5 million 197.0 million
June 30, 2023 500.8 million 207.7 million
March 31, 2023 596.7 million 207.1 million

SNPHF

Price: $9.45

52 week price:
7.17
10.60

Dividend Yield: 2.49%

5-year range yield:
2.49%
4.84%

Forward Dividend Yield: 5.08%

Payout Ratio: 101.28%

Dividend Per Share: 0.48 USD

Earnings Per Share: 0.47 USD

P/E Ratio: 21.15

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Japan

Market Capitalization: 3.5 billion

Average Dividend Frequency: 3

Years Paying Dividends: 20

DGR3: -2.03%

DGR5: 30.00%

DGR10: 30.00%

Links: